At what point did you stop using the lawyer and just start using AI. >> In post, I saw that I can handle this appeal on my own. >> In Southern California, 72-year-old Lynn White was on her own after losing an eviction trial, facing $70,000 in fines and back rent.With no money for an appeals lawyer, she needed a miracle. She found Chat GPT and used it to do the work that would have cost thousands from a trained lawyer. >> It was very helpful.It pointed me to the statutes. AI was helping me draft the motions ...

, /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of KBR, Inc. (NYSE: KBR). Shareholders who purchased shares of KBR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose tha ...

Core Viewpoint - A class action lawsuit has been filed against Savara Inc. for alleged violations of securities laws, specifically related to misleading statements regarding its Biologics License Application (BLA) for MOLBREEVI [1][2]. Group 1: Lawsuit Details - The class period for the lawsuit is from March 7, 2024, to May 23, 2025, with a deadline for lead plaintiff appointments set for November 10, 2025 [2]. - The complaint alleges that Savara made false and misleading statements to the market, particularly regarding the adequacy of information provided in its BLA submitted to the FDA [2]. - It is claimed that the FDA was unlikely to approve Savara's BLA due to deficiencies in the information provided, which rendered the company's public statements materially misleading throughout the class period [2]. Group 2: Shareholder Participation - Shareholders who purchased shares during the specified class period are encouraged to contact the law firm for potential lead plaintiff appointments, although this is not a requirement for recovery [2][3]. - Once registered, shareholders will be enrolled in a portfolio monitoring system to receive updates on the case's status, with no cost or obligation to participate [3]. Group 3: Law Firm Background - DJS Law Group specializes in securities class actions and corporate governance litigation, focusing on enhancing investor returns through advocacy [4]. - The firm represents some of the largest hedge funds and alternative asset managers, emphasizing the value of litigation claims as significant assets [4].

Accessibility StatementSkip Navigation NEW YORK, Sept. 25, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of PubMatic, Inc. (NASDAQ: PUBM). Shareholders who purchased shares of PUBM during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/pubmatic-inc-loss-submission-form/?id=168870&fr ...

NEW YORK, Sept. 24, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Nutex Health Inc. (NASDAQ: NUTX) between August 8, 2024 and August 14, 2025, both dates inclusive (the “Class Period”), of the important October 21, 2025 lead plaintiff deadline. SO WHAT: If you purchased Nutex securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WH ...

Accessibility StatementSkip Navigation MILWAUKEE, Sept. 24, 2025 /PRNewswire/ -- The Ademi Firm is investigating IAS (Nasdaq: IAS) for possible breaches of fiduciary duty and other violations of law in its transaction with Novacap. Shareholders of IAS will receive $10.30 per share in a transaction valued at approximately $1.9 billion. IAS insiders will receive substantial benefits as part of change of control arrangements. The transaction agreement unreasonably limits competing transactions for IAS by impo ...

Core Viewpoint - A class action lawsuit has been filed against Fly-E Group, Inc. for alleged securities fraud and unlawful business practices, following a significant decline in the company's net revenues attributed to recent lithium-battery accidents involving E-Bikes and E-Scooters [2]. Group 1: Lawsuit Details - The class action lawsuit concerns whether Fly-E and certain officers or directors engaged in securities fraud or other unlawful business practices [2]. - Investors have until November 7, 2025, to request the Court to appoint them as Lead Plaintiff if they purchased Fly-E securities during the Class Period [2]. Group 2: Financial Performance - On August 14, 2025, Fly-E reported a 32% decrease in net revenues for the first quarter of fiscal year 2026, primarily due to a decrease in total units sold [2]. - Following the revenue announcement, Fly-E's stock price plummeted by $6.76 per share, or 87.11%, closing at $1.00 per share on August 15, 2025 [2].

NEW YORK--(BUSINESS WIRE)---- $FI #ClassAction--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Fiserv, Inc. ("Fiserv†or the "Company†) (NYSE: FI) and reminds investors of the September 22, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has re ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased securities of RxSight, Inc. during the specified Class Period of the upcoming lead plaintiff deadline for a class action lawsuit [1][2] Group 1: Class Action Details - The class action lawsuit has been filed against RxSight, Inc. for allegedly misleading statements regarding the company's growth and performance during the Class Period [4] - Investors who purchased RxSight securities may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1][2] - The lead plaintiff must file a motion with the Court by September 22, 2025, to represent other class members in the litigation [2] Group 2: Allegations Against RxSight - The lawsuit claims that RxSight misrepresented the effectiveness of its field organization and the adoption rates of newer customer cohorts, which were actually underperforming [4] - It is alleged that the utilization across the installed base was declining, contradicting the company's claims of rising utilization [4] - As a result of these misleading statements, investors purchased shares at artificially inflated prices, leading to financial damages when the truth was revealed [4] Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest against a Chinese company at the time [3] - The firm has been consistently ranked among the top firms for securities class action settlements and has recovered hundreds of millions of dollars for investors [3] - Founding partner Laurence Rosen has been recognized as a leading figure in the plaintiffs' bar, further establishing the firm's credibility [3]

Core Viewpoint - Kuehn Law, PLLC is investigating potential breaches of fiduciary duties by certain officers and directors of Rocket Pharmaceuticals, Inc. [1] Company Summary - Rocket Pharmaceuticals, Inc. is currently under scrutiny for possible misconduct by its leadership, which may affect shareholder interests [1]